doi: 10.3390/pathogens11010084 115 LengS.XuW.WuL.LiuL.DuJ.YangF.et al
Semaglutide, a single-pathway GLP-1 receptor agonist delivered as a weekly subcutaneous injection, positioned by the brand as the most-proven, lowest-entry-cost option
Vancouver Style IEEE Style et al ., Glutamine transporters as effective targets in digestive system malignant tumor treatment, Oncol
En la actualidad, las pautas mdicas siguen siendo cautelosas, pero ahora reconocen que los GLP-1 podran ayudar a algunas personas con diabetes tipo 1, especialmente aquellas con resistencia a la insulina o sobrepeso
Families were contacted via telephone and email reminders, and follow-up appointments were scheduled to coincide with routine clinical care whenever possible
To avoid off-target toxicity, more research is needed to ascertain whether SalB can target key fibrotic components upstream and downstream and whether its use affects the normal repair process in any way